Ifp Advisors, Inc Poly Pid Ltd. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$7.05 - $9.48 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$8.4 - $9.99 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$8.92 - $15.5 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$8.89 - $13.5 $0 - $0	0 New

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $69.6M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.